Weizmann Institute scientists report why taste and smell differ among individuals

"De gustibus non est disputandum" is a popular saying, conveying that one shouldn't argue about flavors. Now, a team at the Weizmann Institute of Science, headed by Prof. Doron Lancet of the Molecular Genetics Department, has found why this is true.

In our genome, around 1,000 genes code for the nose's odor-detecting receptors (responsible for our sense of smell and a great part of flavor perception). Of these, more than half have become totally inactive in all humans, a fact that has been known for years. Now a surprising discovery, published in Nature Genetics, shows that at least 50 genes are "optional" they can be active in some individuals and inactive in others. This high level of genetic variation among individuals is most unusual.

A simple calculation, based on the new findings, shows that nearly every human being would display a different pattern of active/inactive receptors an individualized genetic barcode. The uncovered genetic heterogeneity affects the way thousands of aromas and flavors are perceived.

Furthermore, the new research shows that the level of obliteration of olfactory receptors varies among different ethnic groups.

The novel discovery has profound implications for the way the perfume, food and beverage industries handle the discovery of new aroma, flavor and fragrance ingredients. Usually one person, or a small test panel, makes sensory decisions taken to represent billions of customers. But since every nose is different, industry might rethink such issues. The investigators believe that soon a DNA chip could be used to perform olfactory genetics typing of panels and target audiences alike. Thus, cosmetics and foodstuff design would be revolutionized in much the same way that the drug industry now seriously contemplates developing tailor-made medications based on the breakthroughs of pharmacogenetics.


Contact: Alex Smith
American Committee for the Weizmann Institute of Science

Page: 1

Related biology news :

1. Weizmann scientists invention moves forward: Cancer diagnosis technique gets FDA clearance
2. Psoriasis treatment based on Weizmann Institute Research passes phase II clinical trials
3. Weizmann Institute scienists find that stem cells in the bone marrow become liver cells
4. Weizmann institute scientists solve the 3-D structure of the enzyme involved in Gaucher disease
5. Prize to Weizmann Institute professor for landmark work in stem cell transplantation
6. New witchweed-fighting method, presented by CIMMYT and Weizmann Institute scientist
7. Weizmann Institute scientists win global competition in predicting protein-protein interactions
8. Vaccination following spinal cord injury: Innovative Weizmann Institute approach limits paralysis
9. Weizmann Institute scientists block loss of eyesight in animals with a glaucoma-like disease
10. Weizmann Institute researcher named to Israel Academy Of Sciences And Humanities
11. Weizmann Institute scientists develop a novel system for analyzing genetic data that mimics the human capacity for unsupervised learning

Post Your Comments:

(Date:8/21/2019)... , ... August 20, 2019 , ... ... and commercialization of bioactive technologies for the spine, today announced the 510(K) clearance ... a unique surface modification that is proven to improve osseointegration through superior hydrophilicity ...
(Date:8/15/2019)... TORONTO (PRWEB) , ... August 15, 2019 , ... ... finally passed. Now what? As serialization mandates become increasingly complex, and aggregation becomes ... their current serialization software is the best long-term solution. , Until now, most ...
(Date:8/14/2019)... ... ... Join Jonathan Riek, PhD, VP, Musculoskeletal & Metabolic Imaging, BioTel Research ... EDT to learn about two common imaging methods in NAFLD/NASH to aid with early ... diffuse liver disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... , ... September 16, 2019 , ... ... via CNBC on Saturday, September 21st @11:00am ET. Check local listings for more ... Ltd. (Credo Biomedical), a molecular diagnostic company from Singapore dedicated to developing ...
(Date:9/11/2019)... ... September 10, 2019 , ... Catalent, the leading global provider ... and consumer health products, today announced that Alex Haig, Senior Director, Engineering will ... AG, Schwabisch Hall, Germany, on Sept. 18-19, 2019. , On Wednesday, Sept. 18 ...
(Date:9/2/2019)... , ... September 02, 2019 , ... ... and in vitro diagnostics, has launched the industry’s first epigenetics data mining services ... meaning of epigenetic data and other data types. , Next generation sequencing in ...
(Date:8/27/2019)... HOUSTON (PRWEB) , ... August 27, 2019 , ... ... chain engineering firm, is pleased to announce it has promoted Consulting Engineer, Robert ... Solutions, Battista has added the responsibility of onboarding and mentoring new engineers as ...
Breaking Biology Technology:
Cached News: